A combination of CpG oligonucleotides and polymer microparticles is an extremely effective adjuvant for Neisserial antigens. The invention therefore provides a composition comprising: (a) a Neisserial antigen； (b) a CpG oligonucleotide； and (c) a biodegradable polymer microparticle.
